Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-02

Clinical Trial Update: Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on fecal microbiota transplantation for irritable bowel syndrome, covering Phase 2 and Phase 3 with the study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Aleris-Hamlet Hospitaler København | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: COMPLETED